DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Operating Room Homepage

Philips teams with Medtronic on cryoablation treatment for atrial fibrillation Will form an integrated solution for cryoablation

Court denies Hologic's attempt to halt sale of Minerva's ablation solution Follows a drawn out case over patent infringement

Using comic illustrations to support patient understanding of cardiac catheterization Making patients more satisfied, less anxious and more informed

Improving surgical outcomes by imaging head and neck tumors in real time Researchers use tech developed by Perimeter Medical Imaging

Medical community finds ways to make TAVR safer for at-risk patients Improving outcomes with special procedures

The benefits of intraoperative MR Q&A with Dr. John Huston Mayo Clinic neuroradiologist discusses what the advanced capabilities mean for patients – as well as providers

Surgery gets a little more futuristic with single-incision robotic procedures UT Southwestern's Dr. Jeffrey Cadeddu discusses the da Vinci SP surgical system

What’s new in C-arms and tables? Smaller footprint and dose reduction are defining a new generation of equipment

Mentice partners with RAD-AID to bring interventional radiology training to underserved communities Providing simulator software, hardware and expertise

Smith & Nephew reveal plans to build digital surgery and robotics ecosystem Developing new products, opening new facility, buying business

DBT may reduce breast biopsy rates
for women with benign lesions
better than standard mammography,
according to a new study

3D mammography helps avoid unnecessary breast biopsies, says study

by John R. Fischer , Staff Reporter
A switch from standard to 3D mammography could mean a difference in the number of women with non-malignant lesions who are ordered to undergo breast biopsies following an abnormal mammogram.

That’s according to a single-institution prospective study which found a 33 percent decrease in the biopsy rate for patients assessed with digital breast tomosynthesis scans (DBT), compared to full-field digital mammography screenings (FFDM).

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



“Avoidance of performing a benign biopsy means the women will get the normal results at the clinic and do not have to wait a further week for the biopsy results,” lead researcher Nisha Sharma, director of breast screening and clinical lead for breast imaging at Leeds Teaching Hospital NHS Trust, Seacroft Hospital, in Leeds, England, told HCB News. “This helps reduce anxiety levels and closes the clinical episode, thereby improving the patient pathway. It also reduces the workload for pathology and the number of hospital visits for the women.”

Whereas FFDM captures two X-rays of the breast from top-to-bottom and side-to-side, DBT captures multiple images from different angles which are synthesized by a computer into 3D images.

The study examined 30,933 women who underwent FFDM or screening breast MR through the U.K.’s National Health Service Breast Screening Programme (NHSBSP) between 2015 and 2016 at Seacroft Hospital, and then followed up six weeks after with a DBT scan.

Of the participants, 1,470 (4.8 percent) were recalled for further imaging due to abnormalities found. Following this, a final recall group was established, and consisted of 827 who required 571 biopsies, the rate of which was 69 percent.

The use of biopsies uncovered 142 cancers, compared to 429 cases where the lesions detected were found to be non-cancerous, yielding a benign biopsy rate of 75 percent.

Reading the DBT images while blinded to the original FFDM results, the study’s authors found that DBT imaging would have reduced biopsy numbers on recalled women from 571 to 298, and would still be able to detect all 142 cancers. The result would have been a biopsy rate of 36 percent and a benign biopsy rate of 52 percent.

“The findings here validate that tomosynthesis should be available in all breast clinics as it is an important diagnostic imaging tool,” said Sharma.

The mean age of the final recall group was 56.7.

The findings were published in the journal, Radiology.

Operating Room Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED